LIPPINCOTT ILLUSTRATED REVIEWS:
PHARMACOLOGY — 7TH EDITION
Premium Original Study Guide • Expanded Concepts • Clinical Reasoning • 240 Practice Questions
Purpose. This guide is an original learning resource inspired by the publicly visible topic structure of the referenced Stuvia
listing. It does not reproduce the publisher’s test bank, paid material, answer key, or actual examination questions.
Important edition note. The linked Stuvia listing identifies the 7th edition and shows a 508-page test-bank listing. The current
official publisher catalog now lists later editions, so drug information should be cross-checked against your assigned text and
current clinical references before patient-care use.
,How to Use This Guide
Use a three-pass method: (1) learn the mechanism, (2) connect mechanism to therapeutic effect and toxicity, and (3) answer the
practice questions without looking back. For pharmacology, mechanism → indication → adverse effects →
contraindications/interactions → monitoring is usually more durable than memorizing isolated drug names.
Core framework: PK = what the body does to the drug; PD = what the drug does to the body. Pharmacokinetics includes
absorption, distribution, metabolism and excretion; pharmacodynamics includes receptor effects, dose-response relationships
and clinical effects.
The public preview of the linked document covers Chapter 1 pharmacokinetics and shows the broader 48-chapter structure. The
chapter list below follows that public structure while the explanations and questions are newly written.
Rapid Mastery Checklist
• Know bioavailability, clearance, volume of distribution and half-life.
• Separate potency from efficacy.
• Map autonomic receptors to organ effects.
• Recognize high-risk adverse effects rather than memorizing every side effect.
• Compare drug classes by mechanism and monitoring.
• Use renal/hepatic function to reason about accumulation and dosing.
• Recognize emergency toxicities and the general role of antidotes.
• Apply antimicrobial spectrum, mechanism and resistance principles.
,1. Pharmacokinetics
ADME, bioavailability, first-pass metabolism, distribution, protein binding, clearance, half-life, steady state, loading/maintenance
doses.
ADME
Absorption determines how a drug reaches systemic circulation. Distribution determines where it travels. Metabolism changes
drug structure, often in the liver. Excretion removes drug, commonly through the kidneys.
High-yield equations
Bioavailability is the fraction reaching systemic circulation. Clearance describes the volume of plasma cleared of drug per unit
time. Half-life is the time required for concentration to fall by half. With first-order kinetics, a constant fraction is removed per unit
time.
First-pass effect
Oral drugs may undergo intestinal and hepatic metabolism before reaching systemic circulation. This can lower bioavailability
and make oral exposure differ substantially from IV exposure.
Volume of distribution
A high apparent Vd suggests extensive tissue distribution relative to plasma. A low Vd suggests greater confinement to the
vascular compartment.
Clinical reasoning
When clearance falls, drug exposure can rise and dosing intervals or doses may need adjustment. Renal impairment is
particularly important for drugs predominantly eliminated unchanged by the kidneys.
Exam traps
• Confusing mechanism with indication.
• Assuming a common adverse effect is always the most dangerous one.
• Ignoring kidney/liver function when interpreting accumulation.
• Choosing a drug solely because it is familiar rather than matching the mechanism to the clinical problem.
, 2. Drug–Receptor Interactions & Pharmacodynamics
Agonists, antagonists, partial agonists, potency vs efficacy, dose-response curves, therapeutic index, receptor regulation.
Potency vs efficacy
Potency concerns how much drug is needed for a given effect; efficacy concerns the maximum effect the drug can produce. A
more potent drug is not automatically more clinically effective.
Agonists and antagonists
A full agonist activates a receptor to produce maximal response. A partial agonist activates the receptor but has a lower ceiling
and can reduce the effect of a full agonist when both compete.
Therapeutic index
A narrow therapeutic window means small concentration changes can move a patient from benefit toward toxicity. Such drugs
require careful monitoring.
Receptor adaptation
Repeated stimulation can lead to desensitization or down-regulation; prolonged blockade can produce compensatory changes.
These concepts help explain tolerance and withdrawal phenomena.
Exam traps
• Confusing mechanism with indication.
• Assuming a common adverse effect is always the most dangerous one.
• Ignoring kidney/liver function when interpreting accumulation.
• Choosing a drug solely because it is familiar rather than matching the mechanism to the clinical problem.
PHARMACOLOGY — 7TH EDITION
Premium Original Study Guide • Expanded Concepts • Clinical Reasoning • 240 Practice Questions
Purpose. This guide is an original learning resource inspired by the publicly visible topic structure of the referenced Stuvia
listing. It does not reproduce the publisher’s test bank, paid material, answer key, or actual examination questions.
Important edition note. The linked Stuvia listing identifies the 7th edition and shows a 508-page test-bank listing. The current
official publisher catalog now lists later editions, so drug information should be cross-checked against your assigned text and
current clinical references before patient-care use.
,How to Use This Guide
Use a three-pass method: (1) learn the mechanism, (2) connect mechanism to therapeutic effect and toxicity, and (3) answer the
practice questions without looking back. For pharmacology, mechanism → indication → adverse effects →
contraindications/interactions → monitoring is usually more durable than memorizing isolated drug names.
Core framework: PK = what the body does to the drug; PD = what the drug does to the body. Pharmacokinetics includes
absorption, distribution, metabolism and excretion; pharmacodynamics includes receptor effects, dose-response relationships
and clinical effects.
The public preview of the linked document covers Chapter 1 pharmacokinetics and shows the broader 48-chapter structure. The
chapter list below follows that public structure while the explanations and questions are newly written.
Rapid Mastery Checklist
• Know bioavailability, clearance, volume of distribution and half-life.
• Separate potency from efficacy.
• Map autonomic receptors to organ effects.
• Recognize high-risk adverse effects rather than memorizing every side effect.
• Compare drug classes by mechanism and monitoring.
• Use renal/hepatic function to reason about accumulation and dosing.
• Recognize emergency toxicities and the general role of antidotes.
• Apply antimicrobial spectrum, mechanism and resistance principles.
,1. Pharmacokinetics
ADME, bioavailability, first-pass metabolism, distribution, protein binding, clearance, half-life, steady state, loading/maintenance
doses.
ADME
Absorption determines how a drug reaches systemic circulation. Distribution determines where it travels. Metabolism changes
drug structure, often in the liver. Excretion removes drug, commonly through the kidneys.
High-yield equations
Bioavailability is the fraction reaching systemic circulation. Clearance describes the volume of plasma cleared of drug per unit
time. Half-life is the time required for concentration to fall by half. With first-order kinetics, a constant fraction is removed per unit
time.
First-pass effect
Oral drugs may undergo intestinal and hepatic metabolism before reaching systemic circulation. This can lower bioavailability
and make oral exposure differ substantially from IV exposure.
Volume of distribution
A high apparent Vd suggests extensive tissue distribution relative to plasma. A low Vd suggests greater confinement to the
vascular compartment.
Clinical reasoning
When clearance falls, drug exposure can rise and dosing intervals or doses may need adjustment. Renal impairment is
particularly important for drugs predominantly eliminated unchanged by the kidneys.
Exam traps
• Confusing mechanism with indication.
• Assuming a common adverse effect is always the most dangerous one.
• Ignoring kidney/liver function when interpreting accumulation.
• Choosing a drug solely because it is familiar rather than matching the mechanism to the clinical problem.
, 2. Drug–Receptor Interactions & Pharmacodynamics
Agonists, antagonists, partial agonists, potency vs efficacy, dose-response curves, therapeutic index, receptor regulation.
Potency vs efficacy
Potency concerns how much drug is needed for a given effect; efficacy concerns the maximum effect the drug can produce. A
more potent drug is not automatically more clinically effective.
Agonists and antagonists
A full agonist activates a receptor to produce maximal response. A partial agonist activates the receptor but has a lower ceiling
and can reduce the effect of a full agonist when both compete.
Therapeutic index
A narrow therapeutic window means small concentration changes can move a patient from benefit toward toxicity. Such drugs
require careful monitoring.
Receptor adaptation
Repeated stimulation can lead to desensitization or down-regulation; prolonged blockade can produce compensatory changes.
These concepts help explain tolerance and withdrawal phenomena.
Exam traps
• Confusing mechanism with indication.
• Assuming a common adverse effect is always the most dangerous one.
• Ignoring kidney/liver function when interpreting accumulation.
• Choosing a drug solely because it is familiar rather than matching the mechanism to the clinical problem.
